BioTechxUSA 2026

Biointron is pleased to announce our participation in BioTechX USA 2026, taking place September 29 – 30, 2026, at the Hynes Convention Center in Boston, Massachusetts. 

BioTechX USA brings together leaders from the pharmaceutical, biotechnology, healthcare, and academic sectors to advance collaboration across drug discovery, diagnostics, precision medicine, data science, and digital transformation. The two-day event will welcome more than 1,500 attendees and over 200 speakers, providing a forum for scientific exchange, technology showcases, and industry networking. 

The 2026 program will explore developments across AI-driven drug discovery, bioinformatics and computational R&D, large language models, multiomics, precision medicine, clinical data analytics, and research data management. Through conference sessions, exhibitions, start-up showcases, and one-to-one networking opportunities, attendees can examine how emerging technologies and high-quality experimental data are shaping pharmaceutical research and development. 

Biointron looks forward to connecting with attendees at booth #321. Join us in Boston to discuss antibody discovery, high-throughput antibody expression, and rapid wet-lab data generation for AI-driven antibody development. We look forward to exploring new ideas and collaborations that can help accelerate antibody therapeutic innovation. 

For more details about the event, please visit the BioTechX USA 2026 website [https://www.terrapinn.com/conference/biotechxusa/index.stm] 

Time: September 29 - 30, 2026 

Location: Hynes Convention Center | Boston, MA 

Booth: #321